Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation

Explorative Study of AZD1305 in Atrial Fibrillation Patients

NCT00643448 ·Status: COMPLETED ·Phase: PHASE2

Effect of Diltiazem on Pharmacokinetics of BMS-914392

NCT01211808 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

NCT04083339 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation

NCT01259622 ·Status: TERMINATED ·Phase: PHASE2

Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response

NCT05691959 ·Status: UNKNOWN ·Phase: PHASE2

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

NCT05130268 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction

NCT04308031 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence

NCT04704050 ·Status: TERMINATED ·Phase: PHASE4

Ivabradine for Rate Control in Permanent Atrial Fibrillation

NCT03987204 ·Status: COMPLETED ·Phase: PHASE1

Antiarrythmic Drugs - Long-term Follow-up in the Modern Era

NCT01082055 ·Status: COMPLETED

Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)

NCT04491136 ·Status: TERMINATED ·Phase: PHASE4

Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction

NCT04117009 ·Status: UNKNOWN ·Phase: PHASE4

Safety Study of Tecadenoson to Treat Atrial Fibrillation

NCT00713401 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

NCT00907998 ·Status: COMPLETED ·Phase: PHASE1

Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)

NCT00751738 ·Status: COMPLETED ·Phase: PHASE3

Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation

NCT02764619 ·Status: UNKNOWN ·Phase: PHASE3

American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

NCT00259376 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation

NCT07273994 ·Status: RECRUITING ·Phase: PHASE4

Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:

NCT05151861 ·Status: UNKNOWN ·Phase: PHASE4

COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF

NCT02582190 ·Status: WITHDRAWN ·Phase: PHASE3

Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

NCT02750319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Drug-Induced Sudden Death & Ventricular Arrhythmia

NCT00102180 ·Status: COMPLETED

Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients

NCT02167165 ·Status: COMPLETED

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

NCT00174785 ·Status: COMPLETED ·Phase: PHASE3

Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study

NCT04594746 ·Status: TERMINATED ·Phase: PHASE4